Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Treatment outcome of first episode schizophrenia.

Lieberman J, Jody D, Geisler S, Vital-Herne J, Alvir JM, Walsleben J, Woerner MG.

Psychopharmacol Bull. 1989;25(1):92-6. No abstract available.

PMID:
2772122
2.

Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.

Kopala LC, Fredrikson D, Good KP, Honer WG.

Biol Psychiatry. 1996 Feb 15;39(4):296-8. No abstract available.

PMID:
8645777
3.

Obstetric complications predict treatment response in first-episode schizophrenia.

Alvir JM, Woerner MG, Gunduz H, Degreef G, Lieberman JA.

Psychol Med. 1999 May;29(3):621-7.

PMID:
10405083
4.

Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia.

Uçok A, Polat A, Genç A, Cakir S, Turan N.

J Psychiatr Res. 2004 Mar-Apr;38(2):163-8.

PMID:
14757330
5.

Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.

Gaebel W, Möller HJ, Buchkremer G, Ohmann C, Riesbeck M, Wölwer W, Von Wilmsdorff M, Bottlender R, Klingberg S.

Eur Arch Psychiatry Clin Neurosci. 2004 Apr;254(2):129-40.

PMID:
15146342
6.

Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.

Emsley RA, Oosthuizen PP, Joubert AF, Roberts MC, Stein DJ.

J Clin Psychiatry. 1999 Nov;60(11):747-51.

PMID:
10584762
7.

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA.

Arch Gen Psychiatry. 1999 Mar;56(3):241-7.

PMID:
10078501
8.
9.

Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up.

de Haan L, van Amelsvoort T, Dingemans P, Linszen D.

Pharmacopsychiatry. 2007 Nov;40(6):264-8.

PMID:
18030650
10.

Prevention of negative symptom psychopathologies in first-episode schizophrenia: two-year effects of reducing the duration of untreated psychosis.

Melle I, Larsen TK, Haahr U, Friis S, Johannesen JO, Opjordsmoen S, Rund BR, Simonsen E, Vaglum P, McGlashan T.

Arch Gen Psychiatry. 2008 Jun;65(6):634-40. doi: 10.1001/archpsyc.65.6.634.

PMID:
18519821
11.

Covariance of positive and negative symptoms during neuroleptic treatment in schizophrenia: a replication.

Tandon R, Ribeiro SC, DeQuardo JR, Goldman RS, Goodson J, Greden JF.

Biol Psychiatry. 1993 Oct 1;34(7):495-7. No abstract available.

12.

Neurological soft signs and their relationship to 1-year outcome in first-episode schizophrenia.

Prikryl R, Ceskova E, Kasparek T, Kucerova H.

Eur Psychiatry. 2007 Nov;22(8):499-504. Epub 2007 Jul 5.

PMID:
17614262
13.

Influence of duration of untreated psychosis on auditory P300 in drug-naive and first-episode schizophrenia.

Wang J, Hirayasu Y, Hokama H, Tanaka S, Kondo T, Zhang M, Xiao Z.

Psychiatry Clin Neurosci. 2005 Apr;59(2):209-14.

14.

Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia.

Kane JM, Rifkin A, Quitkin F, Nayak D, Ramos-Lorenzi J.

Arch Gen Psychiatry. 1982 Jan;39(1):70-3.

PMID:
6275811
15.

Testosterone in first-episode schizophrenia.

Cesková E, Prikryl R, Kaspárek T.

Neuro Endocrinol Lett. 2007 Dec;28(6):811-4.

PMID:
18063925
16.

The psychobiology of first-episode schizophrenia.

Waring EM.

Can J Psychiatry. 1995 Sep;40(7 Suppl 2):S33-7. Review.

PMID:
8564915
17.

Brain volume changes in first-episode schizophrenia: a 1-year follow-up study.

Cahn W, Hulshoff Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, Schothorst PF, van Engeland H, Kahn RS.

Arch Gen Psychiatry. 2002 Nov;59(11):1002-10.

PMID:
12418933
18.

Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.

Chakos MH, Alvir JM, Woerner MG, Koreen A, Geisler S, Mayerhoff D, Sobel S, Kane JM, Borenstein M, Lieberman JA.

Arch Gen Psychiatry. 1996 Apr;53(4):313-9.

PMID:
8634009
19.

Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response.

Koreen AR, Lieberman J, Alvir J, Mayerhoff D, Loebel A, Chakos M, Amin F, Cooper T.

Arch Gen Psychiatry. 1994 Feb;51(2):132-8.

PMID:
7905259
20.

Conventional antipsychotic medications for schizophrenia.

Dixon LB, Lehman AF, Levine J.

Schizophr Bull. 1995;21(4):567-77. Review.

PMID:
8749885

Supplemental Content

Support Center